InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Atul Pande, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 14 open-market SEC Form 4 transactions: 2 purchases worth $124K and 12 sales worth $2.7M, reported from Aug 2, 21 to Jul 24, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 24, 26 | IMVTImmunovant, Inc. | SELL | 1.5K | $39.80 | $60K |
| Jun 26, 26 | IMVTImmunovant, Inc. | SELL | 1.5K | $38.01 | $57K |
| Jun 15, 26 | IMVTImmunovant, Inc. | SELL | 1.5K | $34.02 | $51K |
| Dec 2, 24 | IMVTImmunovant, Inc. | SELL | 7.8K | $28.54 | $221K |
| Dec 1, 23 | IMVTImmunovant, Inc. | SELL | 4.8K | $40.46 | $196K |
| Sep 30, 22 | IMVTImmunovant, Inc. | BUY | 15.0K | $5.60 | $84K |
| Feb 1, 22 | KRTXKaruna Therapeutics, Inc. | SELL | 2.5K | $110.80 | $277K |
| Jan 3, 22 | KRTXKaruna Therapeutics, Inc. | SELL | 2.5K | $130.44 | $326K |
| Dec 1, 21 | KRTXKaruna Therapeutics, Inc. | SELL | 2.5K | $127.73 | $319K |
| Nov 1, 21 | KRTXKaruna Therapeutics, Inc. | SELL | 2.5K | $136.67 | $342K |
| Oct 1, 21 | KRTXKaruna Therapeutics, Inc. | SELL | 2.5K | $120.72 | $302K |
| Sep 1, 21 | KRTXKaruna Therapeutics, Inc. | SELL | 2.5K | $117.82 | $295K |
| Aug 13, 21 | IMVTImmunovant, Inc. | BUY | 5.0K | $7.98 | $40K |
| Aug 2, 21 | KRTXKaruna Therapeutics, Inc. | SELL | 2.5K | $114.17 | $285K |